Preparing an Antigen-Adjuvant Emulsion to Induce Autoimmune Encephalomyelitis

Published: August 31, 2023

Abstract

Source: Bäckström, B. T. A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis. J. Vis. Exp. (2022)

This video demonstrates an efficient homogenization technique to generate an antigen-adjuvant emulsion to induce experimental autoimmune encephalomyelitis (EAE) in a murine model. The emulsion contains an autoantigen — myelin oligodendrocyte glycoprotein (MOG) — in the water phase, surrounded by a continuous oil phase comprising an inactivated pathogenic bacteria. The emulsion ensures a sustained release of antigens for a prolonged immune response.

Protocol

All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board.

NOTE: A schematic flow of the method is described in Figure 1.

1. Material preparation

NOTE: Prepare all the reagents aseptically in a sterile hood, and aliquot and store at the indicated temperature. The reagents can be stored for up to 2 years without losing their effect.

  1. Prepare CFA containing 20 mg/mL Mycobacterium tuberculosis as described below.
    1. Add 100 mg of freeze-dried M. tuberculosis H37RA (see Table of Materials) and five 3.2 mm steel beads to a 7 mL tube (see Table of Materials). Shake the tube in a homogenizer (see Table of Materials) for 60 s at the highest speed setting (5,000 rpm).
    2. Add 5 mL of incomplete Freund's adjuvant (IFA) to the tube and shake again for 60 s at the highest speed. Transfer the slurry of homogenized M. tuberculosis in IFA (now named CFA) to a fresh tube with a pipette, leaving the beads behind, and store at 4 °C until use.
  2. Add ultrapure water to the freeze-dried powder of MOG35-55 peptide (see Table of Materials) to obtain a final peptide concentration of 10 mg/mL. Sterilize the solution by passing it through a 0.2 µm filter. Prepare 60 µL aliquots and store at -20 °C until use.
    NOTE: The MOG35-55 peptide used for this experiment is of ImmunoGrade purity (~70%), is TFA-cleaved, dissolves easily in water, and contains a C-terminal amide (-NH2) to increase in vivo stability. Peptide aliquots were never thawed and re-frozen more than twice, and were stored at -20 °C until use.

2. Preparation of CFA/peptide emulsions

  1. Calculate the amount of emulsion needed for immunization. In this standard protocol, each mouse receives 50 µg of MOG35-55 peptide and 300 µg of M. tuberculosis dispersed in Freund's adjuvant (CFA). The amount of each reagent (MOG35-55 peptide, PBS, CFA, and IFA) required for preparing the emulsions can be calculated using Supplemental File 1. An additional 20% of all reagents, to compensate for the small loss of emulsion, is included in the calculation.
    NOTE: The commercial emulsion kit (see Table of Materials) used in this study comprises a tube, screw cap, and a plunger in a sterilized pouch. Each tube of the emulsion kit holds a maximum of 9.6 mL, making it possible to prepare 8 x 1 mL syringes sufficient for immunizing 40 mice (or 80 mice if using 100 µL of emulsion per animal).
  2. Place the screw-capped tube (from the commercial emulsion kit) and reagents to be used on ice.
  3. Add the emulsion components in the following order in the volumes calculated in step 2.1: PBS, then the peptide, then M. tuberculosis in CFA, and finally IFA.
  4. Close the tube with the cap firmly by tightening and loosening it several times. Shake the tube vigorously for 5-10 s by hand to pre-mix the reagents.
  5. Place the tube in the shaking homogenizer and secure it with the rod. Set the speed to the highest setting and the time to 60 s. Once the run is finished, place the tube on ice for 3 min. Repeat the run one or two more times with the same settings.
  6. Centrifuge the tube at 300 x g for 1 min to remove trapped air and compact the emulsion.
  7. Remove the cap from the tube, insert the plunger into the tube, and push it down slowly until it reaches the top of the emulsion. Remove the snap-off closure at the bottom of the tube by twisting it.
  8. Remove the plunger from an injection syringe (1 mL; see Table of Materials). Add a needle (preferably 25-27 G) to the injection syringe.
  9. Attach the back end of the injection syringe to the dedicated lock at the bottom of the tube and lock it with a short twist.
  10. Transfer the emulsion from the tube to the injection syringe by pushing the plunger gently. Stop when the emulsion reaches the 0.15 mL graduation of the injection syringe.
  11. Separate the injection syringe from the tube and insert the plunger carefully, taking care that no air enters the syringe. Push the plunger until the emulsion comes out of the needle.
    NOTE: At this point, some of the emulsion can be used for quality control (see step 3).
  12. Repeat steps 2.8-2.11 for the rest of the emulsion present in the tube.
    NOTE: To minimize the waste of expensive CFA/antigen emulsions, 1 mL syringes should be used. Other syringes that fit the dedicated lock at the bottom of the tube may be used; however, a larger volume of emulsion may need to be prepared. The CFA/MOG35-55 peptide emulsion can be stored at 4 °C for up to 15 weeks without losing its EAE-inducing capacity.

3. Quality control of emulsion

  1. Drop-test: Add a small drop of the emulsion into a sterile 50 mL conical tube filled with 20 mL of cold water. Close the tube and shake it by hand for a couple of seconds. The appearance of tiny distinct droplets confirms the formation of a water-in-oil emulsion.
  2. Examine the emulsion using phase contrast microscopy.
    1. To analyze the size of the water-in-oil particles, add a tiny drop (2-3 µL) of the emulsion to a microscope slide, smear it out with a cover slip, and then push hard in a circular motion to flatten out the emulsion.
    2. Examine the smeared emulsion under a phase contrast microscope (see Table of Materials) with 400x magnification and focus on a field with a monolayer of the emulsion. Ensure that small uniform grey/white particles are visible (Figure 2A).

Representative Results

Figure 1
Figure 1: Schematic of the process of emulsion preparation using a commercial emulsion kit. This figure has been reused from Topping et al with permission.

Figure 2
Figure 2: Characterization of emulsions produced using different methods. (A) Representative images from three different preparation methods: standard homogenization method, traditional syringe method, and vortex method. A small amount of emulsion was placed on a glass slide and observed under a phase contrast microscope (400x). Scale bar = 50 µm. A representative preparation is shown of each method from >15 experiments. The average D (the volume weighted mean) was measured with a particle size analyzer to be 0.7 µm for the shaking homogenization method, 1.4 µm for the syringe method, and 5.4 µm for the vortex method. (B) Stability of the emulsion over time was measured using the particle size analyzer. An emulsion of CFA/PBS was prepared with the shaking homogenizer and the emulsion kit, and the particle size determined, using laser diffraction over time. One sample was analyzed immediately and then the emulsions were stored at 4 °C. These samples were analyzed 1, 2, 4, and 6 weeks after preparation. The average D volume weighted mean for all samples was 0.73 µm ± 0.03 µm (SD). This figure has been reused from Topping et al with permission.

Supplemental File 1: Calculation of the amount of each reagent (MOG35-55 peptide, PBS, CFA, and IFA) for emulsion preparation. Please click here to download this File.

Disclosures

The authors have nothing to disclose.

Materials

1 mL Injection syringe B. Braun 9166017V
1 mL Injection syringe Sigma-Aldrich Z683531
7 ml empty tubes with caps Bertin-Instruments P000944LYSK0A.0 7 mL tube
50 mL sterile centrifuge tube Fisher Scientific 10788561 50 mL tube
Dispersant, light mineral oil Sigma-Aldrich M8410 Store at RT
Emulsion kit Bertin-Instruments D34200.10 ea Containing a tube, cap, and plunger
Incomplete Freund's Adjuvant Sigma-Aldrich F5506 Store at +4 °C
Mycobacterium tuberculosis, H37RA Fisher Scientific DF3114-33-8 Store at +4 °C
Minilys-Personal homogenizer Bertin-Instruments P000673-MLYS0-A Shaking homogenizer
MOG 35-55 Peptide Innovagen N/A
Montanide ISA 51 VG Seppic 36362Z FDA-approved oil adjuvant
Pall Acrodisc Syringe Filters 0.2 μm Fisher Scientific 17124381 Sterile filter
PBS, Ca2+/Mg2+ free Thermo Fisher Scientific 14190144 PBS
Phase-Contrast Microscope Olympus BX40-B
Steel Beads 3.2 mm Fisher Scientific NC0445832 Autoclave and store at RT

Tags

Play Video

Cite This Article
Preparing an Antigen-Adjuvant Emulsion to Induce Autoimmune Encephalomyelitis. J. Vis. Exp. (Pending Publication), e21568, doi: (2023).

View Video